• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Digital health apps may have limited role in reduction of migraine symptoms

bySimon PanandAlex Chan
July 13, 2025
in Chronic Disease, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Among adult patients with migraine headaches, the use of a prescribed digital health app did not reduce the number of migraine days compared with a control app consisting of only migraine diary features. 

Evidence Rating Level: 1 (Excellent)

Current management of migraines includes both pharmacological and nonpharmacological approaches, including the use of migraine diaries. With newer advancements in digital technology, there has been an increase in the number of apps with comprehensive features for the purposes of diary tracking as well as giving behavioural advice. This randomized controlled trial therefor,e sought to investigate one of the most frequently downloaded headache apps that is commercially available in Germany and to compare its efficacy against a traditional app with only migraine diary features. 476 adult participants with a diagnosis of migraines from Germany were randomized to either the intervention group (n = 238; mean[SD] age = 35.6[10.3] years) or the control group (n = 238; mean[SD] age = 34.8[10.5] years). The primary outcome was migraine days per month (defined as 28 days) after 12 weeks. There was no statistical difference in the number of migraine days per month between intervention and control groups (between-group difference [intervention minus control], 0.38 [95% CI, −0.32 to 1.08] days; P = .29). There was a similar reduction in the number of migraine days in both groups (intervention group mean [SD], 7.74 [3.70] days during baseline to an adjusted mean of 5.79 [95% CI, 5.02-6.57] days during weeks 9 to 12; control group mean [SD], 7.76 [3.69] days during baseline to an adjusted mean of 5.41 [95% CI, 4.63-6.19] days during weeks 9 to 12). Overall, this study found that the use of a prescribed digital health app was not associated with a reduction in the number of migraine days compared with a control app consisting of only migraine diary features. 

Click to read the study in JAMA Network Open

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy

A novel validated, imaging-based risk model may predict poststroke epilepsy more accurately than existing tools

Large language models (LLMs) substantially improved patient comprehension of discharge summaries

Tags: AIartificial intelligencedigital healthheadachemigraineneurology
Previous Post

Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction

Next Post

New obesity framework may reclassify over half of overweight individuals as people with obesity

RelatedReports

Imaging and Intervention

Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy

January 15, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Chronic Disease

A novel validated, imaging-based risk model may predict poststroke epilepsy more accurately than existing tools

January 12, 2026
Patients with advanced adenomas are at increased risk of developing colorectal cancer
Artificial Intelligence

Large language models (LLMs) substantially improved patient comprehension of discharge summaries

January 12, 2026
2 Minute Medicine

Machine learning models effectively screened for Parkinson’s disease using smile videos

December 29, 2025
Next Post
Colonic byproduct may decrease long-term weight gain

New obesity framework may reclassify over half of overweight individuals as people with obesity

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

2 Minute Medicine Rewind July 14, 2025

#VisualAbstract: Brain Activation Measured on Functional MRI Predicts Response to Certolizumab, a TNF Inhibitor, in Rheumatoid Arthritis

#VisualAbstract: Brain Activation Measured on Functional MRI Predicts Response to Certolizumab, a TNF Inhibitor, in Rheumatoid Arthritis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ethosuximide may not be effective for the treatment of abdominal pain in irritable bowel syndrome
  • Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy
  • Yartemlea (narsoplimab-wuug) improves platelets hemolysis organ function hematopoietic stem cell transplant–associated thrombotic microangiopathy transplant patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.